NCT05320380 2023-09-01
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat
Children's Oncology Group
Phase 1/2 Withdrawn
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Bristol-Myers Squibb
Ohio State University Comprehensive Cancer Center
University of Louisville
AIDS Malignancy Consortium